NCCN Task Force: Clinical utility of PET in a variety of tumor types Journal Article


Authors: Podoloff, D. A.; Ball, D. W.; Ben-Josef, E.; Benson, A. B. 3rd; Cohen, S. J.; Coleman, R. E.; Delbeke, D.; Ho, M.; Ilson, D. H.; Kalemkerian, G. P.; Lee, R. J.; Loeffler, J. S.; Macapinlac, H. A.; Morgan, R. J. Jr; Siegel, B. A.; Singhal, S.; Tyler, D. S.; Wong, R. J.
Article Title: NCCN Task Force: Clinical utility of PET in a variety of tumor types
Abstract: Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments. © Journal of the National Comprehensive Cancer Network.
Keywords: review; cancer radiotherapy; pancreas cancer; nuclear magnetic resonance imaging; positron emission tomography; radiopharmaceuticals; neoplasm; neoplasms; colorectal cancer; computer assisted tomography; breast cancer; classification; lung non small cell cancer; cancer research; urogenital tract cancer; sarcoma; hypoxia; utilization review; lung small cell cancer; diagnostic agent; uterine cervix cancer; lymphoma; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; positron-emission tomography; radiopharmaceutical agent; scintiscanning; stomach cancer; liver cancer; brain cancer; 1 fluoro 3 (2 nitro 1 imidazolyl) 2 propanol f 18; thyroid cancer; pancreatic cancer; esophagus cancer; pet; 3' fluorothymidine f 18; choline c 11; gynecologic cancer; biliary tract cancer; esophageal cancer; myeloma; pet/ct; tirapazamine; gastric cancer; genitourinary cancers; gynecological cancers; small cell lung cancer; methionine c 11
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 7
Issue: Suppl. 2
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2009-06-01
Start Page: S1
End Page: S23
Language: English
PUBMED: 19555588
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 30 November 2010" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Richard J Wong
    412 Wong
  2. David H Ilson
    433 Ilson
Related MSK Work